You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Dextrose; magnesium acetate; potassium acetate; sodium chloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for dextrose; magnesium acetate; potassium acetate; sodium chloride and what is the scope of freedom to operate?

Dextrose; magnesium acetate; potassium acetate; sodium chloride is the generic ingredient in one branded drug marketed by Icu Medical Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for dextrose; magnesium acetate; potassium acetate; sodium chloride
Recent Clinical Trials for dextrose; magnesium acetate; potassium acetate; sodium chloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alphacait, LLCPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2
University of IoanninaPhase 4

See all dextrose; magnesium acetate; potassium acetate; sodium chloride clinical trials

US Patents and Regulatory Information for dextrose; magnesium acetate; potassium acetate; sodium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium acetate; potassium acetate; sodium chloride INJECTABLE;INJECTION 017610-001 Approved Prior to Jan 1, 1982 RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Dextrose; magnesium acetate; potassium acetate; sodium chloride Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Dextrose; Magnesium Acetate; Potassium Acetate; Sodium Chloride

Introduction

The combination of dextrose, magnesium acetate, potassium acetate, and sodium chloride is commonly used in medical solutions, particularly for intravenous (IV) fluids. This mixture is crucial for maintaining daily fluid and electrolyte requirements, especially in clinical settings. Here, we will delve into the market dynamics and financial trajectory of this drug combination.

Market Overview

Demand and Usage

The demand for IV solutions containing dextrose, magnesium acetate, potassium acetate, and sodium chloride is driven by the need for fluid and electrolyte replacement in various medical conditions. These solutions are widely used in hospitals, clinics, and other healthcare facilities to maintain hydration, restore electrolyte balance, and provide minimal carbohydrate calories[4].

Market Segmentation

The market can be segmented based on the type of solution (e.g., isotonic, hypotonic), the patient population (e.g., pediatric, adult), and the clinical application (e.g., surgery, intensive care).

Key Players

Manufacturers

Companies like ICU Medical Inc., B. Braun Medical Inc., and Industria Farmaceutica Galenica Senese S.R.L. are prominent manufacturers of these IV solutions. These companies play a significant role in the market by ensuring a steady supply of high-quality products[2][4].

Distribution Channels

The distribution channels include pharmaceutical wholesalers, hospital purchasing departments, and online medical supply stores. The efficiency of these channels directly impacts the availability and pricing of the products.

Financial Trajectory

Revenue Trends

The revenue generated from the sale of these IV solutions has been steadily increasing due to the consistent demand from healthcare facilities. The market is expected to continue growing as the global healthcare sector expands and the need for fluid and electrolyte replacement solutions increases.

Pricing Dynamics

The pricing of these solutions can vary based on the concentration of the electrolytes, the volume of the solution, and the brand. For instance, solutions like Normosol-M and 5% Dextrose Injection are priced based on their electrolyte composition and the volume of the solution, with prices ranging from a few dollars to several tens of dollars per liter, depending on the packaging and distribution[4].

Cost Factors

The cost of production includes the cost of raw materials (dextrose, magnesium acetate, potassium acetate, and sodium chloride), manufacturing processes, and regulatory compliance. Additionally, factors such as transportation, storage, and marketing contribute to the final cost of the product.

Regulatory Environment

Approval and Compliance

These IV solutions must comply with stringent regulatory requirements to ensure safety and efficacy. For example, solutions like Normosol-M and 5% Dextrose Injection are approved by regulatory bodies such as the FDA and must adhere to Good Manufacturing Practices (GMP)[4].

Safety and Efficacy

Regulatory bodies closely monitor the safety and efficacy of these solutions. For instance, warnings and contraindications related to the use of these solutions in patients with specific conditions, such as congestive heart failure or severe renal insufficiency, are strictly enforced[4].

Competitive Landscape

Market Competition

The market for IV solutions is competitive, with several manufacturers offering similar products. The competition is driven by factors such as product quality, pricing, and customer service. Companies that innovate in terms of product formulation, packaging, and delivery systems can gain a competitive edge.

Differentiation Strategies

Manufacturers differentiate their products through various strategies, including the use of proprietary formulations, enhanced packaging for ease of use, and strong distribution networks. For example, some solutions may offer a more balanced electrolyte composition or additional ingredients that provide specific clinical benefits.

Future Outlook

Market Growth

The market for IV solutions containing dextrose, magnesium acetate, potassium acetate, and sodium chloride is expected to grow due to increasing healthcare needs, particularly in aging populations and in regions with expanding healthcare infrastructure.

Technological Advancements

Advancements in medical technology, such as improved IV administration systems and more efficient manufacturing processes, can drive market growth by enhancing product safety, efficacy, and convenience.

Emerging Trends

Emerging trends include the development of more specialized IV solutions tailored to specific patient needs, such as pediatric or geriatric populations. There is also a growing focus on sustainability and environmental impact in the production and packaging of these solutions.

Key Takeaways

  • Consistent Demand: The demand for IV solutions containing dextrose, magnesium acetate, potassium acetate, and sodium chloride remains consistent due to their essential role in clinical care.
  • Regulatory Compliance: Strict regulatory requirements ensure the safety and efficacy of these solutions.
  • Competitive Market: The market is competitive, with manufacturers differentiating their products through quality, pricing, and innovation.
  • Future Growth: The market is expected to grow driven by increasing healthcare needs and technological advancements.

FAQs

What are the primary uses of IV solutions containing dextrose, magnesium acetate, potassium acetate, and sodium chloride?

These solutions are used for maintaining daily fluid and electrolyte requirements, restoring hydration, and providing minimal carbohydrate calories in clinical settings.

Who are the key players in the market for these IV solutions?

Key players include ICU Medical Inc., B. Braun Medical Inc., and Industria Farmaceutica Galenica Senese S.R.L.

What factors influence the pricing of these IV solutions?

Pricing is influenced by the concentration of electrolytes, volume of the solution, brand, and distribution channels.

What are the regulatory requirements for these IV solutions?

These solutions must comply with FDA regulations and adhere to Good Manufacturing Practices (GMP) to ensure safety and efficacy.

What are the future trends in the market for these IV solutions?

Future trends include the development of specialized solutions, technological advancements in IV administration, and a focus on sustainability in production and packaging.

Sources

  1. Evaluation of Alternative Anti-Icing and Deicing Compounds Using Laboratory and Field Tests - This source, although not directly related to the topic, provides context on the use of various chemical compounds in different applications, highlighting the importance of careful selection and testing.
  2. Drug Price Increases Report - October 2024 - This report lists various medical products, including those containing the mentioned electrolytes, and provides insights into pricing trends.
  3. Magnesium Acetate Tetrahydrate - DrugBank - This source details the chemical and pharmacological properties of magnesium acetate tetrahydrate, one of the components in the IV solutions.
  4. Normosol-M and 5% Dextrose Injection - This source provides detailed information on the composition, indications, and contraindications of IV solutions containing dextrose, magnesium acetate, potassium acetate, and sodium chloride.
  5. Dextrose; Magnesium Acetate; Potassium Acetate; Sodium Chloride - This source summarizes the chemical information of the components in the IV solutions.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.